Zogenix Inc. buy marge
Start price
07.09.18
/
50%
€40.27
Target price
04.11.21
€79.00
Performance (%)
-66.60%
End price
05.11.21
€13.45
Summary
This prediction ended on 05.11.21 with a price of €13.45. Massive losses of -66.60% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Zogenix Inc. | - | - | - | - |
iShares Core DAX® | -0.284% | -1.519% | 15.326% | 16.634% |
iShares Nasdaq 100 | 3.902% | 5.242% | 31.471% | 56.359% |
iShares Nikkei 225® | 2.335% | 1.663% | 7.422% | 6.486% |
iShares S&P 500 | 2.818% | 2.879% | 25.986% | 48.637% |
Comments by marge for this prediction
In the thread Zogenix Inc. diskutieren
Zogenix mit Aufwärtspotential
Zogenix with positive results from a Phase 2 clinical trial evaluating ZX008 in patients with Lennox-Gastaut syndrome (LGS), a rare and severe type of childhood epilepsy.
Zogenix initiated with Buy rating and $116 (154% upside) price target at B. Riley FBR citing upside for ZX008.
In the thread Trading Zogenix Inc.
Die von marge gewählte maximale Laufzeit wurde überschritten